trial · primary record
ALN-CIDEB
Metabolic Dysfunction-Associated Steatotic Liver Disease
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1500 |
| Primary completion | 2029-03-03 |
| Primary endpoint | Occurrence of Treatment Emergent Adverse Events (TEAEs) |
| Registry ID | NCT07854782 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:26.091Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07854782
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.